Find Geldanamycin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 30562-34-6, Chebi:5292, Nsc-122750, Z3k3vj16ku, U-29135, Mfcd00274570
Molecular Formula
C29H40N2O9
Molecular Weight
560.6  g/mol
InChI Key
QTQAWLPCGQOSGP-KSRBKZBZSA-N
FDA UNII
Z3K3VJ16KU

Geldanamycin
Geldanamycin is a benzoquinone antineoplastic antibiotic isolated from the bacterium Streptomyces hygroscopicus. Geldanamycin binds to and inhibits the cytosolic chaperone functions of heat shock protein 90 (HSP90). HSP90 maintains the stability and functional shape of many oncogenic signaling proteins; the inhibition of HSP90 promotes the proteasomal degradation of oncogenic signaling proteins that may be over-expressed or overactive in tumor cells. (NCI04)
1 2D Structure

Geldanamycin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
2.1.2 InChI
InChI=1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1
2.1.3 InChI Key
QTQAWLPCGQOSGP-KSRBKZBZSA-N
2.1.4 Canonical SMILES
CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC
2.1.5 Isomeric SMILES
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)/C)OC)OC(=O)N)\C)C)O)OC
2.2 Other Identifiers
2.2.1 UNII
Z3K3VJ16KU
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Geldanomycin

2.3.2 Depositor-Supplied Synonyms

1. 30562-34-6

2. Chebi:5292

3. Nsc-122750

4. Z3k3vj16ku

5. U-29135

6. Mfcd00274570

7. [(3r,5s,6r,7s,8e,10s,11s,12z,14e)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] Carbamate

8. Gdm

9. Nsc 122750

10. (4e,6z,8s,9s,10e,12s,13r,14s,16r)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl Carbamate

11. Unii-z3k3vj16ku

12. 1yet

13. [8s-(4e,6z,8r*,9r*,10e,12r*,13s*,14r*,16s*)]-9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione

14. Geldanamycin (9ci)

15. Brn 1633093

16. Geldanamycin [mi]

17. Schembl4154

18. U 29135

19. Bspbio_001073

20. Gtpl9829

21. Dtxsid7042691

22. Geldanamycin Ready Made Solution

23. Schembl13037476

24. Chebi:91381

25. Hms1362e15

26. Hms1792e15

27. Hms1990e15

28. Hms3403e15

29. Bdbm50008059

30. Ei-280

31. Akos024456552

32. Zinc100064834

33. Ccg-208040

34. Db02424

35. Idi1_002122

36. Ncgc00163449-01

37. Ncgc00163449-02

38. 2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9,13-dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, 9-carbamate (8ci)

39. Geldanamycin From Streptomyces Hygroscopicus

40. G0334

41. Sr-05000002266

42. A1-50253

43. J-018017

44. J-521410

45. Sr-05000002266-3

46. Brd-k11528507-001-01-8

47. Geldanamycin, Streptomyces Hygroscopicus - Cas 30562-34-6

48. Geldanamycin From Streptomyces Hygroscopicus, >=98% (hplc), Powder

49. [(3s,5s,6r,7s,8e,10r,11s,12z,14e)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] Carbamate

50. [(4e,6z,8s,9s,10e,12s,13r,14s,16r)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] Carbamate

51. 2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, (4e,6z,8s,9s,10e,12s,13r,14s,16r)-

52. 2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, [8s-(4e,6z,8r*,9r*,10e,12r*,13s*,14r*,16s*)]-

53. Gmy

2.4 Create Date
2005-06-01
3 Chemical and Physical Properties
Molecular Weight 560.6 g/mol
Molecular Formula C29H40N2O9
XLogP32
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count5
Exact Mass560.27338086 g/mol
Monoisotopic Mass560.27338086 g/mol
Topological Polar Surface Area164 Ų
Heavy Atom Count40
Formal Charge0
Complexity1150
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count3
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


Cysteine Proteinase Inhibitors

Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)


Antibiotics, Antineoplastic

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1648751400,"product":"GELDANAMYCIN","address":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3","city":"","supplier":"COMBI BLOCKS INC","supplierCountry":"UNITED STATES","foreign_port":"SAN DIEGO","customer":"SYNGENE INTERNATIONAL LIMITED","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"201","unit":"GMS","unitRateFc":"8.4","totalValueFC":"1711.8","currency":"USD","unitRateINR":"642.6","date":"01-Apr-2022","totalValueINR":"129153","totalValueInUsd":"1711.8","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"1004560","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"SAN DIEGO","supplierAddress":"N\/A","customerAddress":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3"}]
01-Apr-2022
01-Apr-2022
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty